Osteopontin in chronic puromycin aminonucleoside nephrosis

Journal of the American Society of Nephrology

Volumn 8, Issue 9, 1997, Pages 1383-1390

  Magil, Alex B ^a,c   Pichler, Raimund H ^b   Johnson, Richard J ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c ST PAUL S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOPONTIN; PUROMYCIN AMINONUCLEOSIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FOCAL GLOMERULOSCLEROSIS; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; RAT;

EID: 0030828112     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/asn.v891383     Document Type: Article

References (47)

1. Denhardt DT, Guo X: Osteopontin: A protein with diverse functions. FASEB J 7: 1475-1482, 1993
2. Rodan GA: Osteopontin overview. Ann NY Acad Sci 760: 1-5, 1995
3. Giachelli CM, Pichler R, Lombardi D, Denhardt DT, Alpers CE, Schwartz SM, Johnson RJ: Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis. Kidney Int 45: 515-524, 1994
4. Worcester EM, Kleinman JG, Keshensky AM: Osteopontin production by cultured kidney cells. Ann NY Acad Sci 760: 266-278, 1995
5. Diamond JR, Kees-Folts D, Ricardo SD, Pruznak A, Eufemio M: Early and persistent up-regulated expression of renal cortical osteopontin in experimental hydronephrosis. Am J Pathol 146: 1455-1466, 1995
6. Kasugai S, Zhang Q, Overall CM, Wrana JL, Butler WT, Sodek J: Differential regulation of the 55 and 44 kDa forms of the secreted phosphoprotein 1 (SPP-1, osteopontin) in normal and transformed rat bone cells by osteotropic hormones, growth factors and a tumour promoter. Bone Miner 13: 235-250, 1991
7. Sodek J, Chen J, Nagata T, Kasugai S, Todescan R Jr, Li IW, Kim RH: Regulation of osteopontin expression in osteoblasts. Ann NY Acad Sci 760: 223-241, 1995
8. Pollack SB, Linnemeyer PA, Gill S: Induction of osteopontin mRNA expression during activation of murine NK cells. J Leukocyte Biol 55: 398-400, 1994
9. Padanilam BJ, Martin DR, Hammerman MR: Insulin-like growth factor I-enhanced renal expression of osteopontin after acute ischemic injury in rats. Endocrinology 137: 2133-2140, 1996
10. Singh RP, Patarca R, Schwartz J, Singh P, Cantor H: Definition of a specific interaction between the early T lymphocyte activation 1 (Eta-1) protein and murine macrophages in vitro and its effect upon macrophages in vivo. J Exp Med 171: 1931-1942, 1990
11. Pichler R, Giachelli CM, Lombardi D, Pippin J, Gordon K, Alpers CE, Schwartz SM, Johnson RJ: Tubulointerstitial disease in glomerulonephritis: Potential role of osteopontin (uropontin). Am J Pathol 144: 915-926, 1994
12. Pichler RH, Franceschini N, Young BA, Hugo C, Andoh TF, Burdmann EA, Shankland SJ, Alpers CE, Bennett WM, Couser WG, Johnson RJ: Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontin. J Am Soc Nephrol 6: 1186-1196, 1995
13. Diamond JR, Karnovsky MJ: Focal and segmental glomerulosclerosis following a single intravenous dose of puromycin aminonucleoside. Am J Pathol 122: 481-487, 1986
14. Diamond JR, Karnovsky MJ: Exacerbation of chronic aminonucleoside nephrosis by dietary cholesterol supplementation. Kidney Int 32: 671-677, 1987
15. Liaw L, Almeida M, Hart CE, Schwartz SM, Giachelli CM: Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cell in vitro. Circ Res 74: 214-224, 1994
16. Giachelli CM, Bae N, Lombardi D, Majesky M, Schwartz S: Molecular cloning and characterization of 2B7, a rat mRNA which distinguishes smooth muscle cell phenotypes in vitro and is identical to osteopontin (secreted phosphoprotein I, 2aR). Biochem Biophys Res Commun 177: 867-873, 1991
17. Murry CE, Giachelli CM, Schwartz SM, Vracko R: Macrophages express osteopontin during repair of myocardial necrosis. Am J Pathol 145: 1450-1462, 1994
18. Kleinman JG, Beshensky A, Worcester EM, Brown D: Expression of osteopontin, a urinary inhibitor of stone mineral crystal growth, in rat kidney. Kidney Int 47: 1585-1596, 1995
19. Kees-Folts D, Sadow JL, Schreiner GF: Tubular catabolism of albumin is associated with the release of an inflammatory lipid. Kidney Int 45: 1697-1709, 1994
20. Magil A, Feng L: Monocyte chemotactic protein-1 (MCP-1) mRNA expression in acute puromycin aminonucleoside nephrosis (PAN) [Abstract]. Lab Invest 74: 168A, 1996
21. Eddy AA, Warren JS: Expression and function of monocyte chemoattractant protein-1 in experimental nephrotic syndrome. Clin Immunol Immunopathol 78: 140-151, 1996
22. Kasiske BL, O'Donnell MP, Schmitz PG, Kim Y, Keane WF: Renal injury of diet-induced hypercholesterolemia in rats. Kidney Int 37: 880-891, 1990
23. Grone H-F, Walli A, Grone E, Niedmann P, Thiery J, Seidel D, Helmchen U: Induction of glomerulosclerosis by dietary lipids: A functional and morphologic study in the rat. Lab Invest 60: 433-446, 1989
24. van Goor H, Fidler V, Weening JJ, Grond J: Determinants of focal and segmental glomerulosclerosis in the rat after renal ablation: Evidence for involvement of macrophages and lipids. Lab Invest 64: 754-765, 1991
25. van Goor H, Ding G, Kees-Folts D, Grond G, Schreiner GF, Diamond JR: Biology of disease: Macrophages and renal disease. Lab Invest 71: 456-464, 1994
26. Pichler R, Giachelli C, Young B, Alpers CE, Couser WG, Johnson RJ: The pathogenesis of tubulointerstitial disease associated with glomerulonephritis: The glomerular cytokine theory. Miner Electrolyte Metab 21: 317-327, 1995
27. Fukui M, Nakamura T, Ebihara I, Nagaoka I, Tomino Y, Koide H: Low-protein diet attenuates increased gene expression of platelet-derived growth factor and transforming growth factor-β in experimental glomerular sclerosis. J Lab Clin Med 121: 224-234, 1993
28. Ding G, Pesek-Diamond I, Diamond JR: Cholesterol, macrophages, and gene expression of TGF-β and fibronectin during nephrosis. Am J Physiol 264: F577-F584, 1993
29. Ding G, van Goor H, Frye J, Diamond JR: Transforming growth factor-β expression in macrophages during hypercholesterolemic states. Am J Physiol 267: F937-F944, 1994
30. Anderson S, Diamond JR, Karnovsky MJ, Brenner BM: Mechanisms underlying transition from acute glomerular injury to late glomerular sclerosis in a rat model of nephrotic syndrome. J Clin Invest 82: 1757-1768, 1988
31. Diamond JR, Anderson S: Irreversible tubulointerstitial damage associated with chronic aminonucleoside nephrosis: Amelioration by angiotensin I converting enzyme inhibition. Am J Pathol 137: 1323-1332, 1990
32. 1 expression determines growth response to angiotensin II. J Clin Invest 90: 456-461, 1992
33. Grone H-J, Weber K, Grone E, Helmchen U, Osborn M: Coexpression of keratin and vimentin in damaged and regenerating tubular epithelia of the kidney. Am J Pathol 129: 1-8, 1987
34. Moll R, Hage C, Thoenes W: Expression of intermediate filament proteins in fetal and adult human kidney: Modulations of intermediate filament patterns during development and in damaged tissue. Lab Invest 65: 74-86, 1991
35. Eddy AA, McCulloch L, Liu E, Adams J: A relationship between proteinuria and acute tubulointerstitial disease in rats with experimental nephrotic syndrome. Am J Pathol 138: 1111-1123, 1991
36. Magil AB: Tubulointerstitial lesions in young Zucker rats. Am J Kidney Dis 25: 478-485, 1995
37. Johnson RJ, Alpers CE, Yoshimura A, Lombardi D, Pritzl P, Floege J, Schwartz SM: Renal injury from angiotensin II-mediated hypertension. Hypertension 19: 464-474, 1992
38. Harris KPG, Lefkowith JB, Klahr S, Schreiner GF: Essential fatty acid deficiency ameliorates acute renal dysfunction in the rat after administration of the aminonucleoside of puromycin. J Clin Invest 86: 1115-1123, 1990
39. Hwang S-M, Lopez CA, Heck DE, Gardner CR, Laskin DL, Laskin JD, Denhardt DT: Osteopontin inhibits induction of nitric oxide synthase gene expression by inflammatory mediators in mouse kidney epithelial cells. J Biol Chem 269: 711-715, 1994
40. Hwang S-M, Wilson PD, Laskin JD, Denhardt DT: Age and development-related changes in osteopontin and nitric oxide synthase mRNA levels in human kidney proximal tubule epithelial cells: Contrasting responses to hypoxia and reoxygenation. J Cell Physiol 160: 61-68, 1994
41. Singh K, Balligand J-L, Fischer TA, Smith TW, Kelly RA: Glucocorticoids increase osteopontin expression in cardiac myocytes and micrvascular endothelial cells: role in regulation of inducible nitric oxide synthase. J Biol Chem 270: 28471-28478, 1995
42. Narita I, Border WA, Ketteler M, Noble NA: Nitric oxide mediates immunologic injury to kidney mesangium in experimental glomerulonephritis. Lab Invest 72: 17-24, 1995
43. Raij L, Baylis C: Glomerular actions of nitric oxide. Kidney Int 48: 20-32, 1995
44. Noris M, Ruggenenti P, Todeschini M, Figliuzzi M, Macconi D, Zoja C, Paris S, Gaspari F, Remuzzi G: Increased nitiric oxide formation in recurrent thrombotic microangiopathies: A possible mediator of microvascular injury. Am J Kidney Dis 27: 790-796, 1996
45. Diamond JR, Pesek I: Glomerular tumour necrosis factor and interleukin 1 during acute aminonucleoside nephrosis: An immunohistochemical study. Lab Invest 64: 21-28, 1991
46. Gomez-Chiarri M, Ortiz A, Lerma JL, Lopez-Armada MJ, Mampaso F, Gonzalez E, Egido J: Involvement of tumour necrosis factor and platelet-activating factor in the pathogenesis of experimental nephrosis in rats. Lab Invest 70: 449-459, 1994
47. Markewitz BA, Michael JR, Kohan DE: Cytokine-induced expression of a nitric oxide synthase in rat renal tubule cells. J Clin Invest 91: 2138-2143, 1993